RESUMEN
In anaerobic bioreactors, the electrons produced during the oxidation of organic matter can potentially be used for the biological reduction of pharmaceuticals in wastewaters. Common electron transfer limitations benefit from the acceleration of reactions through utilization of redox mediators (RM). This work explores the potential of carbon nanomaterials (CNM) as RM on the anaerobic removal of ciprofloxacin (CIP). Pristine and tailored carbon nanotubes (CNT) were first tested for chemical reduction of CIP, and pristine CNT was found as the best material, so it was further utilized in biological anaerobic assays with anaerobic granular sludge (GS). In addition, magnetic CNT were prepared and also tested in biological assays, as they are easier to be recovered and reused. In biological tests with CNM, approximately 99% CIP removal was achieved, and the reaction rates increased ≈1.5-fold relatively to the control without CNM. In these experiments, CIP adsorption onto GS and CNM was above 90%. Despite, after applying three successive cycles of CIP addition, the catalytic properties of magnetic CNT were maintained while adsorption decreased to 29 ± 3.2%, as the result of CNM overload by CIP. The results suggest the combined occurrence of different mechanisms for CIP removal: adsorption on GS and/or CNM, and biological reduction or oxidation, which can be accelerated by the presence of CNM. After biological treatment with CNM, toxicity towards Vibrio fischeri was evaluated, resulting in ≈ 46% detoxification of CIP solution, showing the advantages of combining biological treatment with CNM for CIP removal.
Asunto(s)
Ciprofloxacina/metabolismo , Electrones , Nanopartículas de Magnetita/química , Nanotubos de Carbono/química , Aguas del Alcantarillado/microbiología , Contaminantes Químicos del Agua/metabolismo , Adsorción , Aliivibrio fischeri/efectos de los fármacos , Aliivibrio fischeri/crecimiento & desarrollo , Anaerobiosis/fisiología , Biodegradación Ambiental , Reactores Biológicos , Ciprofloxacina/aislamiento & purificación , Humanos , Nanopartículas de Magnetita/ultraestructura , Methanobacterium/metabolismo , Methanobrevibacter/metabolismo , Methanosarcinales/metabolismo , Methanospirillum/metabolismo , Pruebas de Sensibilidad Microbiana , Nanotubos de Carbono/ultraestructura , Oxidación-Reducción , Contaminantes Químicos del Agua/aislamiento & purificaciónRESUMEN
Antibiotics in the effluents of municipal wastewater treatment plants (WWTP) may create selective pressures to induce antibiotic resistance in bacteria downstream. This study evaluates ciprofloxacin (CIP) removal by a freshwater alga, Scenedesmus dimorphus, to assess the efficacy of algae-based tertiary treatment in reducing effluent-induced CIP resistance. Results show significant CIP removal in light-exposed samples without algae and experimental algae (EA) samples: 53% and 93%, respectively, over 144â¯h. A residual antibiotic potency assay reveals that untreated CIP is significantly more growth-inhibiting to a model bacterium (Escherichia coli) than the algae-treated and light-exposed samples during short exposures (6â¯h). Adaptive laboratory evolution (ALE), again using E. coli, reveals that treated samples exhibit reduced capacity to elicit CIP resistance during sustained exposures compared to untreated CIP. Finally, observed CIP resistance in the CIP-exposed ALE lineages is corroborated via genotype characterization, which reveals the presence of resistance-associated mutations in gyrase subunit A (gyrA) that are not present in ALE lineages exposed to algae treated or light-exposed samples. As such, algae-mediated tertiary treatment could be effective in suppressing CIP resistance in bacterial communities downstream from WWTP. In addition, ALE is useful for assessing the potential of wastewater-relevant samples to elicit antibiotic resistance downstream.
Asunto(s)
Antibacterianos/farmacología , Ciprofloxacina/farmacología , Farmacorresistencia Bacteriana/efectos de los fármacos , Scenedesmus/metabolismo , Eliminación de Residuos Líquidos/métodos , Antibacterianos/aislamiento & purificación , Antibacterianos/metabolismo , Ciprofloxacina/aislamiento & purificación , Ciprofloxacina/metabolismo , Girasa de ADN/genética , Farmacorresistencia Bacteriana/genética , Escherichia coli/efectos de los fármacos , Escherichia coli/genética , Genotipo , Pruebas de Sensibilidad Microbiana , Mutación , Aguas Residuales/química , Contaminantes Químicos del Agua/aislamiento & purificación , Contaminantes Químicos del Agua/metabolismo , Contaminantes Químicos del Agua/farmacologíaRESUMEN
Magnetic biochar (M-BC) was derived from herbal medicine waste, Astragalus membranaceus residue, and was used as an adsorbent for ciprofloxacin removal from aqueous solutions. The M-BC was characterized by Brunauer-Emmett-Teller surface area analyses, Fourier transform infrared spectrometry, X-ray diffraction analysis, hysteresis loops, scanning electron microscopy energy-dispersive spectrometry, and X-ray photoelectron spectroscopy. The BET surface area increased from 4.40 to 203.70 m2/g after pyrolysis/magnetic modification. Batch experiments were performed at different dosages, initial concentrations, contact times, and solution pHs. Adsorption performances were evaluated using Langmuir and Freundlich isotherm models, and the results indicated that the Langmuir model appropriately described the adsorption process. The kinetic data were better fitted by a pseudo-second-order kinetic model. The maximum ciprofloxacin removal was observed at pH 6 (adsorption capacity of 68.9 ± 3.23 mg/g). Studies demonstrated that magnetically modified biochar might be an attractive, cost-effective, and easily separated adsorbent for contaminated water. Graphical abstract.
Asunto(s)
Carbón Orgánico/química , Ciprofloxacina/aislamiento & purificación , Contaminantes Químicos del Agua/aislamiento & purificación , Purificación del Agua/métodos , Adsorción , Astragalus propinquus/química , Ciprofloxacina/química , Cinética , Fenómenos Magnéticos , Microscopía Electrónica de Rastreo , Espectroscopía de Fotoelectrones , Soluciones , Espectroscopía Infrarroja por Transformada de Fourier , Propiedades de Superficie , Contaminantes Químicos del Agua/química , Purificación del Agua/economía , Difracción de Rayos XRESUMEN
With more pharmaceuticals and personal care products detected in the surface and waste waters, studies on interactions between these contaminants and soils or sediments have attracted great attention. In this study, the removal of ciprofloxacin (CIP), a fluoroquinolone antibiotic, by birnessite, a layered manganese oxide, in aqueous solution was investigated by batch studies supplemented by X-ray diffraction (XRD) and Fourier transform infrared analyses. Stoichiometric release of exchangeable cations accompanying CIP removal from water confirmed cation exchange as the major mechanism for CIP uptake by birnessite. Interlayer expansion after CIP adsorption on birnessite as revealed by XRD analyses indicated that intercalation contributed significantly to CIP uptake in addition to external surface adsorption. Correlation of CIP adsorption to specific surface area and cation exchange capacity suggested that the former was the limiting factor for CIP uptake. At the adsorption maximum, CIP molecules formed a monolayer on the birnessite surfaces. The adsorbed CIP could be partially removed using a cationic surfactant at a low initial concentration and mostly removed by AlCl3 at a higher initial concentration, which further supported the cation exchange mechanism for CIP removal by birnessite. The results indicated that the presence of layered Mn-oxide in the soil and waste water treatment systems may provide host for CIP accumulation.
Asunto(s)
Antiinfecciosos/aislamiento & purificación , Ciprofloxacina/aislamiento & purificación , Óxidos/química , Contaminantes Químicos del Agua/aislamiento & purificación , Purificación del Agua/métodos , Adsorción , Antibacterianos/farmacología , Antiinfecciosos/análisis , Calibración , Cationes , Cetrimonio , Compuestos de Cetrimonio/química , Ciprofloxacina/análisis , Fluoroquinolonas/química , Concentración de Iones de Hidrógeno , Compuestos de Manganeso/química , Espectrofotometría , Espectroscopía Infrarroja por Transformada de Fourier , Propiedades de Superficie , Tensoactivos , Agua/química , Contaminantes Químicos del Agua/análisis , Difracción de Rayos XRESUMEN
An easy, selective, and sensitive method has been developed for the determination of enrofloxacin (ENR) and its main active metabolite, ciprofloxacin (CIP), in raw bovine milk using CE with UV detection at 268 nm. Milk samples were prepared by a clean-up/extraction procedure based on protein precipitation with hydrochloride acid followed by being defatted by centrifugation and SPE using a hydrophilic-lipophilic balance cartridge. Optimum separation was obtained using a 50 mM phosphoric acid at pH 8.4 and the total electrophoretic run time was 6 min. Sample preparation by this method yielded clean extracts with quantitative and consistent mean recoveries from 89 to 97% for CIP and from 93 to 98% for ENR. LODs obtained were lower to the maximum residue limits for these fluoroquinolones. The precision of the ensuing method is acceptable; thus, the RSD for peak area and migration time was less than 8.5 and 0.5% for CIP and 9.9 and 0.9% for ENR, respectively. The results showed that the proposed method was efficient showing good recoveries, sensitivity, and precision for the studied compounds and could be satisfactorily applied in routine analysis for the monitoring of ENR and CIP residues in milk, due to its ruggedness and feasibility demonstrated.
Asunto(s)
Ciprofloxacina/análisis , Residuos de Medicamentos/análisis , Fluoroquinolonas/análisis , Leche/química , Animales , Bovinos , Fraccionamiento Químico , Ciprofloxacina/aislamiento & purificación , Residuos de Medicamentos/aislamiento & purificación , Electroforesis Capilar/métodos , Enrofloxacina , Fluoroquinolonas/aislamiento & purificación , Límite de Detección , Reproducibilidad de los Resultados , TemperaturaRESUMEN
Pseudomonas aeruginosa es un microorganismo oportunista frecuentemente implicado en infecciones de origen nosocomial que presenta resistencia natural y adquirida a muchos de los antimicrobianos de uso clínico. Se llevo a cabo un estudio de resistencias a antimicrobianos de 3.029 aislamientos de P. aeruginosa de enfermos intra y extrahospitalarios en el periodo 2005-2010. La metodología utilizada fue, el método semiautomatizado WIDER I (Soria Melguizo), para la identificación de las especies y para el estudio de sensibilidades a antimicrobianos. Se consideraron los criterios de sensibilidad y resistencia recomendados por el grupo MENSURA. En nuestro hospital existe un mantenimiento relativo de la sensibilidad antimicrobiana de P. aeruginosa en el periodo 2005-2010, con un aumento de esta en amikacina, gentamicina y cefalosporinas. Existen diferencias de porcentajes de sensibilidades entre las cepas de origen intrahospitalario y extrahospitalario, salvo para fosfomicina y tobramicina. Destacamos la importancia de realizar estudios locales de la sensibilidad y resistencias de P. aeruginosa en cada zona, de forma periódica para poder valorar las diferentes pautas terapéuticas, no siendo posible extrapolar los datos de las diferentes regiones españolas(AU)
Pseudomonas aeruginosa is an opportunistic microorganism that is frequently the cause of nosocomial infections. Multiple mechanisms are involved in its natural and acquired resistance to many of the antimicrobial agents commonly used in clinical practice. We performed an antibiotic resistance study on P. aeruginosa isolated from intrahospitalary and extrahospitalary samples between 2005 and 2010 years. We included in the study a global amount of 3,029 P. aeruginosa isolates from clinical samples received at University Hospital Reina Sofia. Microbiology Service in Córdoba (Spain). Semiautomatic system WIDER I for strains identification and sensibility testing was employed. We considered susceptibility and resistance criteria recommended by MENSURA group. Results of the analysis showed that P. aeruginosa maintanied similar levels of antimicrobial susceptibility during the period 2005-2010, with increased susceptibility to amikacin, gentamicin and cefalosporins. There were also important differences in the degree of susceptibility between intrahospital and extrahospital strains during 2010 year, except for tobramicin and fosfomycin. The intrahospital difference in susceptibility was also evaluated, emphasizing the importance of periodically surveillance of susceptibility and resistance patterns of P. aeruginosa, in each setting in order to evaluate different therapeutic guidelines, because it is not always advisable to extrapolate data from different regions(AU)
Asunto(s)
Humanos , Masculino , Femenino , Pseudomonas aeruginosa , Antiinfecciosos/uso terapéutico , Tobramicina/uso terapéutico , Cefalosporinas/uso terapéutico , Piperacilina/aislamiento & purificación , Ceftazidima/aislamiento & purificación , Amicacina/aislamiento & purificación , Gentamicinas/aislamiento & purificación , Fosfomicina/aislamiento & purificación , Ciprofloxacina/aislamiento & purificación , Sensibilidad y Especificidad , Ticarcilina/aislamiento & purificación , Pseudomonas aeruginosa/aislamiento & purificación , Ticarcilina/farmacocinética , Piperacilina/farmacocinética , Ceftazidima/farmacocinética , Amicacina/farmacocinética , Gentamicinas/farmacocinética , Fosfomicina/farmacocinética , Ciprofloxacina/farmacocinéticaRESUMEN
Objetivo. Las infecciones por Staphylococcus coagulasa negativos (CNS) resistentes a meticilina aumentado considerablemente en los pacientes hospitalizados. Hemos estudiado la actividad de vancomicina, ciprofloxacino, daptomicina y linezolid en cepas de CNS resistente a meticilina aisladas en hemocultivos clínicamente significativos. Material y Métodos. Se estudiaron 87 cepas de distintas especies de CNS de hemocultivos positivos. Los estafilococos fueron identificados mediante el sistema automático MicroScan Walkaway (Dade Behring, Siemens) y con Api ID 32 Staph (Bio- Merieux, Francia). La sensibilidad a oxacilina, vancomicina y ciprofloxacino fue realizada por dicho sistema MicroScan. La susceptibilidad frente a daptomicina y linezolid fue realizada mediante Etest (AB BioMerieux, Solna, Suecia). Para los criterios de interpretación se siguieron las indicaciones del CLSI. Resultados. Se estudiaron 87 cepas, 55 (63%) fueron S. epidermidis, 15 (17%) fueron S. haemolyticus, 10 (12%) fueron S. hominis, y 7 (8%) pertenecieron a otras especies. 53 (61%) cepas presentaron una MIC para vancomicina de 2 mg/L. La resistencia a ciprofloxacino, MIC > 2 mg/L fue observada en 56 (64%) cepas. No se encontraron resistencia a daptomicina, con un rango de sensibilidad entre 0.032-1 mg/L y un valor modal de 0,25 mg/L. Se aislaron 10 (11,5%) cepas resistentes a linezolid. Nueve pacientes estuvieron ingresados en la Unidad de Cuidados Intensivos, donde la estancia media fue de 38 días (rango 16-58 días), y uno perteneció al Servicio de Cirugía Hepato-Pancreática, con una estancia de 64 días. Conclusiones. Es frecuente aislar cepas de CNS con pérdida de sensibilidad para vancomicina en nuestro hospital, mientras que daptomicina presenta una alta sensibilidad frente a este tipo de microorganismos. El uso masivo y continuado de linezolid ha llevado a la aparición de resistencias(AU)
Objective. Multiresistant coagulase-negative staphylococci (CNS) infections are mainly increased in hospitalized patients. We have studied the activity of vancomycin, ciprofloxacin, daptomycin and linezolid in methicillin-resistant CNS strains, isolated from true blood cultures. Methods. We collected 87 strains of different CNS species from positive blood cultures. Staphylococci were identified by MicroScan Walkaway (Dade Behring, Siemens) and with the Api ID 32 Staph (BioMerieux, France). The susceptibility to oxacillin, vancomycin and ciprofloxacin was performed by automatic microdilution plate as cited above. The susceptibility to daptomycin and linezolid was performed by Etest (AB BioMerieux, Solna, Sweden). Interpretative criteria were done following the CLSI guidelines. Results. Eighty-seven CNS strains were studied: 55 (63%) were S. epidermidis, 15 (17%) S. haemolyticus, 10 (12%) S. hominis, and 7 (8%) other species. Fifty-three (61%) strains showed loss of susceptibility to vancomycin, MIC = 2 mg/L. Ciprofloxacin resistance, MIC > 2 mg/L, was observed in 56 (64%) strains. Daptomycin resistance was not observed, with a susceptibility range between 0.032-1 mg/L and modal value of 0.25 mg/L. Ten strains (11.5%) resistant to linezolid were observed. Nine patients were in ICU, where the average length of stay was 38 days (range 16- 58 days) and one belonged to Hepato-Pancreatic Surgery, where he stayed for 64 days. Conclusions. Low susceptibility to vancomycin is frecuent in the CNS strains studied in our hospital. Daptomycin shows a high efficacy against CNS, and it could be useful for the treatment of primary bacteremia or catheter associated bacteremia. The massive and continuous use of linezolid has led to the appearance of resistance(AU)
Asunto(s)
Humanos , Masculino , Femenino , Vancomicina/uso terapéutico , Ciprofloxacina/uso terapéutico , Daptomicina/uso terapéutico , Staphylococcus , Staphylococcus/aislamiento & purificación , Resistencia a la Meticilina , Ciprofloxacina/síntesis química , Vancomicina/aislamiento & purificación , Vancomicina/metabolismo , Vancomicina/farmacología , Ciprofloxacina/aislamiento & purificación , Ciprofloxacina/farmacología , Daptomicina/síntesis química , Daptomicina/metabolismo , Sensibilidad y EspecificidadRESUMEN
Residual antibiotics reaching the colon have many deleterious effects on the colonic microbiota including the selection of new antibiotic resistances. In order to avoid the selection of ciprofloxacin resistance, intestine or colon-targeted zinc-pectinate beads containing activated charcoal (AC) were designed for the inactivation of residual ciprofloxacin in the gastrointestinal tract of rats. Bead stability after oral administration was adjusted by tuning the concentration of zinc in the gelling bath and the number of washings. Intestine and colon-targeted beads were administered along with 50mg/kg of ciprofloxacin and ciprofloxacin was dosed in the plasma and the feces using HPLC. Ciprofloxacin pharmacokinetics was not affected by the oral co-administration of beads. The co-administration of intestine-targeted beads led to a significant decrease of the residual fecal free ciprofloxacin with a pronounced dose effect. Our study suggests the rat model is not appropriate for the investigation of bacteria responsive colon-targeted beads probably due to the important anatomical and physiological differences between human and rat gastrointestinal tracts. The ability of AC loaded zinc-pectinate beads to selectively decrease the intestinal residual fraction of ciprofloxacin could provide a better protection of the intestinal microbiota and may prevent the emergence of ciprofloxacin resistance in the gastrointestinal tract.
Asunto(s)
Antibacterianos/aislamiento & purificación , Carbón Orgánico , Ciprofloxacina/aislamiento & purificación , Colon/química , Pectinas/química , Animales , Antibacterianos/farmacocinética , Cromatografía Líquida de Alta Presión , Ciprofloxacina/farmacocinética , Masculino , Microscopía Electrónica de Rastreo , Ratas , Ratas Sprague-DawleyRESUMEN
Water and wastewater effluents contain a vast range of chemicals in mixtures that have different chemical structures and characteristics. This study presents a treatment technology for the removal of mixtures of antibiotic residues (sulfamethoxazole (SMX), oxytetracycline (OTC) and ciprofloxacin (CIP)) from contaminated water. The treatment combines pH modification of the water to an optimal value, followed by a photolytic treatment using direct polychromatic ultraviolet (UV) irradiation by medium pressure UV lamp. The pH adjustment of the treated water leads to structural modifications of the pollutant's molecule thus may enhance direct photolysis by UV light. Results showed that an increase of water pH from 5 to 7 leads to a decrease in degradation rate of SMX and an increase in degradation rate of OTC and CIP, when studied separately and not in a mixture. Thus, the optimal pH values for UV photodegradation in a mixture, involve initial photolysis at pH 5 and then gradually changing the pH from 5 to 7 during the UV exposure. For example, this resulted in 99% degradation of SMX at pH 5 and enhanced degradation of OTC and CIP from 54% and 26% to 91% and 96% respectively when pH was increased from 5 to 7. Thus the pH induced photolytic treatment has a potential in improving treatment of antibiotics in mixtures.
Asunto(s)
Antibacterianos/aislamiento & purificación , Ciprofloxacina/aislamiento & purificación , Oxitetraciclina/aislamiento & purificación , Sulfametoxazol/aislamiento & purificación , Rayos Ultravioleta , Contaminantes Químicos del Agua/aislamiento & purificación , Purificación del Agua/métodos , Antibacterianos/química , Ciprofloxacina/química , Concentración de Iones de Hidrógeno , Cinética , Espectrometría de Masas/métodos , Modelos Químicos , Oxitetraciclina/química , Fotoquímica/métodos , Fotólisis , Sulfametoxazol/química , Eliminación de Residuos Líquidos , Agua/químicaRESUMEN
Infrared spectrophotometric analysis (FTIR) was performed on a crystalline deposit developed in a corneal ulcer by an old woman who received ciprofloxacine ophthalmic drops. We collected the data of the literature on the subject. After in vitro crystallization experiments, we conclude that ciprofloxacin and norfloxacin corneal precipitates occur at physiological lachrymal pH with magnesium.
Asunto(s)
Ciprofloxacina/aislamiento & purificación , Ciprofloxacina/uso terapéutico , Úlcera de la Córnea/patología , Úlcera de la Córnea/fisiopatología , Norfloxacino/uso terapéutico , Anciano , Ciprofloxacina/administración & dosificación , Cristalización , Femenino , Fluoroquinolonas/aislamiento & purificación , Fluoroquinolonas/uso terapéutico , Humanos , Concentración de Iones de Hidrógeno , Magnesio/farmacología , Norfloxacino/administración & dosificación , Norfloxacino/aislamiento & purificación , Soluciones Oftálmicas , Espectroscopía Infrarroja por Transformada de Fourier , Lágrimas/efectos de los fármacos , Lágrimas/fisiologíaRESUMEN
PURPOSE: To determine the antibacterial activity of the white crystalline precipitate formed on the corneal surface after topical administration of 0.3% ciprofloxacin ophthalmic solution by microbiologic assay. METHODS: White crystalline precipitate formed on the corneal surface of seven patients was scraped and individually dissolved in sterile distilled water. Quantification by high-performance liquid chromatography (HPLC) and microbiologic assay of ciprofloxacin in the precipitate solutions were done. Microbiologic assay was performed by agar diffusion method against Klebsiella pneumoniae. RESULTS: By HPLC, concentrations of ciprofloxacin were estimated to be 1.5-60 microg/ml in the dissolved precipitate obtained from six patients, whereas the concentrations based on microbiologic assay varied from 1.6 to 16.1 microg/ml. Ciprofloxacin was not detected by either method in the precipitate obtained from one patient. The antibacterial activity (microg/ml) determined by microbiologic assay was not related to the actual amount of ciprofloxacin in the solutions as estimated by HPLC in cases 1, 2, 4, and 7. It was almost the same in the solutions from cases 5 and 6. CONCLUSION: The white crystalline precipitate formed on the corneal surface after topical administration of 0.3% ciprofloxacin ophthalmic solution exhibited bacterial inhibitory activity, indicating that the precipitate may function as a drug depot.